Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.

作者: Sean C. Dowdy , Michael Stefanek , Lynn C. Hartmann

DOI: 10.1016/J.AJOG.2004.04.028

关键词: OophorectomyBreast cancerProphylactic OophorectomyRisk factorProphylactic SurgerySurgeryMastectomyProspective cohort studyMedicineProphylactic Mastectomy

摘要: Investigators have used retrospective and prospective study designs to provide much needed data on the extent of risk reduction after prophylactic oophorectomy mastectomy in women at increased for breast ovarian cancer. In this publication we identify those who may wish consider surgery, review demonstrating efficacy discuss potential surgical complications. We also present about frequency use psychosocial impact surgery typically young group women. Finally, general treatment guidelines practicing clinician.

参考文章(74)
Elizabeth M. Swisher, David G. Mutch, Sheri Babb, Janet S. Rader, Alison Whelan, Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction. Journal of Reproductive Medicine. ,vol. 46, pp. 87- 94 ,(2001)
H E Averette, R E Estape, S E Sightler, G M Boike, Ovarian cancer in women with prior hysterectomy : a 14-year experience at the University of Miami Obstetrics & Gynecology. ,vol. 78, pp. 681- 684 ,(1991)
Tucker Ma, Struewing Jp, Ponder Ba, Watson P, Lynch Ht, Easton Df, Prophylactic oophorectomy in inherited breast/ovarian cancer families. Journal of The National Cancer Institute Monographs. pp. 33- 35 ,(1995)
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
Charles L. Shapiro, Judith Manola, Meryl Leboff, Ovarian Failure After Adjuvant Chemotherapy Is Associated With Rapid Bone Loss in Women With Early-Stage Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 3306- 3311 ,(2001) , 10.1200/JCO.2001.19.14.3306
E. Warner, D. B. Plewes, R. S. Shumak, G. C. Catzavelos, L. S. Di Prospero, M. J. Yaffe, V. Goel, E. Ramsay, P. L. Chart, D. E.C. Cole, G. A. Taylor, M. Cutrara, T. H. Samuels, J. P. Murphy, J. M. Murphy, S. A. Narod, Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 3524- 3531 ,(2001) , 10.1200/JCO.2001.19.15.3524
Karen H. Lu, Judy E. Garber, Daniel W. Cramer, William R. Welch, Jonathan Niloff, Deborah Schrag, Ross S. Berkowitz, Michael G. Muto, Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. Journal of Clinical Oncology. ,vol. 18, pp. 2728- 2732 ,(2000) , 10.1200/JCO.2000.18.14.2728
Alison Fry, Robert Rush, Camille Busby-Earle, Ann Cull, Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer? Preventive Medicine. ,vol. 33, pp. 578- 585 ,(2001) , 10.1006/PMED.2001.0924